Quantinuum Sets IPO Terms Targeting Up to 1 Billion Raise at 13 Billion Valuation
VF Corporation Draws Jim Cramers Attention as Potential Fantastic Buying Opportunity After Earnings Dip
Deutsche Bank Maintains Positive Stance on Salesforce as Citi Adjusts Price Target Lower
Google Employee Charged in 1 Million Polymarket Insider Trading Case
IonQ Shares Surge as US Quantum Funding Plan and Record Q1 Results Boost Sector Optimism
Central Bank of India Shares Decline as Government Launches 8 Stake Sale via Offer for Sale
HDB Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher
Kaiser Aluminum Q1 2026 Earnings Massive EPS Beat Drives Shares Higher
Bicycle Therapeutics BCYC Q1 2026 Earnings WiderthanExpected Loss as Pipeline Development Continues
AMPY Q1 2026 Earnings Significant earnings miss as reported loss of 093 per share versus consensus estimate
Genpact G Q1 2026 Earnings EPS Beat Drives Investor Focus on Margin Strength
Visa Q1 2026 Earnings EPS Beats Estimates by 482 as Payments Volume Remains Resilient
The European Equity Fund Inc EEA Sees Modest Gains Testing Key Resistance
Zura Bio Limited ZURA Climbs 238 Testing Resistance at 453
Howmet Aerospace HWM Gains Ground as Aerospace Demand Remains a Key Catalyst
First Hawaiian FHB Dips 084 as Technical Indicators Point to Key Support Test
FlyE Group Inc FLYE Soars 10 Key Levels to Watch After Breakout
Lennar LEN Q1 2026 Earnings EPS Miss Highlights Ongoing Housing Market Headwinds
Performance Shipping Inc PSHG Q4 2025 Earnings EPS Beats Estimates Amid Shipping Market Headwinds
CalMaine Foods Inc CALM Q1 2026 Earnings Egg Producer Beats Estimates as Margin Recovery Lifts Bottom Line
AMPY Q1 2026 Earnings Massive EPS Miss Overshadowed by Positive Stock Reaction
BFLY Q1 2026 Earnings EPS Beat Surprises as Butterfly Network Posts Narrower Loss
Vistagen Therapeutics Q1 2026 Earnings Narrower Loss Than Expected Boosts Investor Sentiment
M1 Kliniken AG Completes Capital Reduction via Cancellation of Treasury Shares
BBAR Q4 2025 Earnings Earnings Beat Estimates Despite Stock Decline
Quince Therapeutics QNCX Jumps 9 Testing Key Resistance at 126